Fox Run Management »

Denali Therapeutics shares owned by Fox Run Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Fox Run Management from 13F filings

Historical chart of Fox Run Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Fox Run Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Fox Run Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $368k 13k 29.51
2023-03-31 $205k 8.9k 23.04
2022-09-30 $460k 15k 30.71